Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Gestational Response, Outcomes, and Weight After GLP-1 Use

University of Kansas Medical Center · NCT07743567

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–45 · Women only
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
400
US sites recruiting
1
Study start
April 13, 2026
Record last updated
August 4, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The goal of this observational study is to learn if using GLP-1RA medications for weight loss before pregnancy influences gestational weight gain and pregnancy outcomes. The main aims of the study are to:

  • Compare gestational weight gain between women with preconception GLP-1RA exposure and those without exposure.
  • Compare obstetrical outcomes between women with preconception GLP-1RA exposure and those without exposure.

Researchers will compare pregnant women with a history of GLP-1RA use to pregnant women who have not used a GLP-1RA to compare differences.

Participants will be asked to complete questionnaires at multiple timepoints during and after pregnancy that ask questions about medication history, thoughts and feelings around food, etc.

Conditions: Pregnant Individuals; Obesity & Overweight; Gestational Weight Gain

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Adult women
  • Less than or equal to 20 weeks gestation at first visit
  • English speaking

Exclusion Criteria

  • \<18 years at time of initial visit
  • Type 2 diabetes
  • History of bariatric surgery
  • Multiple gestation
  • Cannot consent for themselves
  • Cannot read and speak English
  • Incarcerated

Recruiting US locations

  • University of Kansas Medical Center

    Kansas City, KS 66160

    Site contact: Molly Fain · 913-588-5478 · mfain3@kumc.edu

Study contacts (from the official record)

  • Molly Fain · 913-588-5478 · mfain3@kumc.edu
All weight loss studies in Kansas →
Gestational Response, Outcomes, and Weight After GLP-1 Use (NCT07743567) | Bored Studies